V Suzanne Klimberg
Role not yet determined Is this you? Add your title
Also affiliated: Alaska Neurology Center (2026); The University of Texas Medical Branch at Galveston (2026)
Research Areas
Biomedical Subjects
Links
Biography and Research Information
OverviewAI-generated summary
V Suzanne Klimberg's research focuses on the intraoperative treatment of breast cancer, specifically investigating the use of ablation techniques to achieve clear margins after lumpectomy. Klimberg is involved in a prospective Phase II multicenter trial, ABLATE (Ablation after Breast Lumpectomy Added To Extend Intraoperative Margins for the Sole Local Treatment of Breast Cancer). This trial examines ablation as a sole local treatment for breast cancer, aiming to improve outcomes by ensuring adequate surgical margins. Klimberg's work also includes producing visual abstracts to disseminate trial findings. Her scholarly contributions, as indicated by her h-index and publication metrics, are associated with ongoing clinical research in breast cancer management.
Metrics
- h-index: 14
- Publications: 58
- Citations: 649
Selected Publications
-
Baseline proteomic biomarkers for predicting chemotherapy-induced cardiotoxicity in breast cancer patients (2026)
-
ASO Visual Abstract: Prospective Phase II Multicenter Trial of Ablation after Breast Lumpectomy Added To Extend (ABLATE) Intraoperative Margins for the Sole Local Treatment of Breast Cancer (2026)
-
Prospective Phase II Multicenter Trial of Ablation after Breast Lumpectomy Added To Extend (ABLATE) Intraoperative Margins for the Sole Local Treatment of Breast Cancer (2026)
-
Doxorubicin Activates Ryanodine Receptors in Rat Lymphatic Muscle Cells to Attenuate Rhythmic Contractions and Lymph Flow (2019)
-
Guidelines for Guidelines: An Assessment of the American Society of Breast Surgeons Contralateral Prophylactic Mastectomy Consensus Statement (2016)
-
Exploiting the tear proteome for the diagnosis of breast cancer (2010)
-
1–29 Intraoperative Cytologic Examination of Breast Sentinel Lymph Nodes: Test Utility and Patient Impact (2005)
-
Use and specificity of breast cancer antigen/milk protein BA46 for generating anti-self-cytotoxic T lymphocytes by recombinant adeno-associated virus-based gene loading of dendritic cells (2004)
-
In situ breast cancer (2000)
Collaboration Network
Top Collaborators
- Effect of Glutamine on Methotrexate Efficacy and Toxicity
- Glutamine Facilitates Chemotherapy While Reducing Toxicity
- Prevention of chronic radiation enteropathy by dietary glutamine
- Advantages of the Papillon protocol in the preoperative treatment of rectal carcinoma
- Effect of Glutamine on Methotrexate Efficacy and Toxicity
- Glutamine Facilitates Chemotherapy While Reducing Toxicity
- Advantages of the Papillon protocol in the preoperative treatment of rectal carcinoma
- In situ breast cancer
- Prospective Phase II Multicenter Trial of Ablation after Breast Lumpectomy Added To Extend (ABLATE) Intraoperative Margins for the Sole Local Treatment of Breast Cancer
- ASO Visual Abstract: Prospective Phase II Multicenter Trial of Ablation after Breast Lumpectomy Added To Extend (ABLATE) Intraoperative Margins for the Sole Local Treatment of Breast Cancer
- Glutamine Enhances Gut Glutathione Production
- Effect of Glutamine on Methotrexate Efficacy and Toxicity
- Glutamine Facilitates Chemotherapy While Reducing Toxicity
- Prevention of chronic radiation enteropathy by dietary glutamine
- Glutamine Facilitates Chemotherapy While Reducing Toxicity
- Prevention of chronic radiation enteropathy by dietary glutamine
- Glutamine Facilitates Chemotherapy While Reducing Toxicity
- Advantages of the Papillon protocol in the preoperative treatment of rectal carcinoma
- Prospective Phase II Multicenter Trial of Ablation after Breast Lumpectomy Added To Extend (ABLATE) Intraoperative Margins for the Sole Local Treatment of Breast Cancer
- ASO Visual Abstract: Prospective Phase II Multicenter Trial of Ablation after Breast Lumpectomy Added To Extend (ABLATE) Intraoperative Margins for the Sole Local Treatment of Breast Cancer
- Prospective Phase II Multicenter Trial of Ablation after Breast Lumpectomy Added To Extend (ABLATE) Intraoperative Margins for the Sole Local Treatment of Breast Cancer
- ASO Visual Abstract: Prospective Phase II Multicenter Trial of Ablation after Breast Lumpectomy Added To Extend (ABLATE) Intraoperative Margins for the Sole Local Treatment of Breast Cancer
- Prospective Phase II Multicenter Trial of Ablation after Breast Lumpectomy Added To Extend (ABLATE) Intraoperative Margins for the Sole Local Treatment of Breast Cancer
- ASO Visual Abstract: Prospective Phase II Multicenter Trial of Ablation after Breast Lumpectomy Added To Extend (ABLATE) Intraoperative Margins for the Sole Local Treatment of Breast Cancer
- Prospective Phase II Multicenter Trial of Ablation after Breast Lumpectomy Added To Extend (ABLATE) Intraoperative Margins for the Sole Local Treatment of Breast Cancer
- ASO Visual Abstract: Prospective Phase II Multicenter Trial of Ablation after Breast Lumpectomy Added To Extend (ABLATE) Intraoperative Margins for the Sole Local Treatment of Breast Cancer
- Prospective Phase II Multicenter Trial of Ablation after Breast Lumpectomy Added To Extend (ABLATE) Intraoperative Margins for the Sole Local Treatment of Breast Cancer
- ASO Visual Abstract: Prospective Phase II Multicenter Trial of Ablation after Breast Lumpectomy Added To Extend (ABLATE) Intraoperative Margins for the Sole Local Treatment of Breast Cancer
- Prospective Phase II Multicenter Trial of Ablation after Breast Lumpectomy Added To Extend (ABLATE) Intraoperative Margins for the Sole Local Treatment of Breast Cancer
- ASO Visual Abstract: Prospective Phase II Multicenter Trial of Ablation after Breast Lumpectomy Added To Extend (ABLATE) Intraoperative Margins for the Sole Local Treatment of Breast Cancer
- Prospective Phase II Multicenter Trial of Ablation after Breast Lumpectomy Added To Extend (ABLATE) Intraoperative Margins for the Sole Local Treatment of Breast Cancer
- ASO Visual Abstract: Prospective Phase II Multicenter Trial of Ablation after Breast Lumpectomy Added To Extend (ABLATE) Intraoperative Margins for the Sole Local Treatment of Breast Cancer
- Prospective Phase II Multicenter Trial of Ablation after Breast Lumpectomy Added To Extend (ABLATE) Intraoperative Margins for the Sole Local Treatment of Breast Cancer
- ASO Visual Abstract: Prospective Phase II Multicenter Trial of Ablation after Breast Lumpectomy Added To Extend (ABLATE) Intraoperative Margins for the Sole Local Treatment of Breast Cancer
Similar Researchers
Based on overlapping research topics